Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
A lot changed in my opinion, 29 Nov announcement was a good thing but then it's gdr and people didn't expect it will happen on time ,some even said average time for this is 4-6weeks so who knows maybe delay maybe it wont happen etc ,brave ones jumped in and risk was higher than it is now ,when they delivered CE mark before 10 days + it's looking good for testing Omicron ,that was untested on 29th, possible contract confirmation again and looks like this time bod will deliver , question remains ,are we waiting for contracts in next few days ,maybe even today or it's a job for new year ,another delay or no contract at all. For now it feels like market expecting contract very soon so people buying is logical
Looking for experienced sales professionals within the COVID testing market looking to move to a wider and more responsible role, developing relationships across Europe for our exciting new COV19-ID Kit Point of Care assay. Experience of establishing relationships with COVID testing facilities, distributors and point of care settings would be especially useful. The role will not only look to develop and maintain key distribution agreements, but expand into other markets and be involved in the product life cycle development as VOC, as well as growing in scope and responsibility along with the product line and company,.
This will go again tomorrow,it's midday RNS not the morning when when you have whole day to see where sp is going ,gap up tomorrow and after lunch we will see how strong is the rise ,my guess is 75 open rising to 95-105 and dip after 1pm to 85 to scare some and see the behaviour of small pi ,then wwe go again and close anywhere over a 100 will be spectacular
Gdr is better than this ,placing or delist here
Next news
Clinical test data available on Genedrive® COV19-ID Kit
• Genedrive® COV19-ID Kit CE mark
• KOL sites installation for AIHL in UK
• Commercial partner launch of Genedrive® COV19-ID Kit.
• Publication of AIHL Performance Trial Data
• CoV-POC sal s target updates
• Launch of AIHL assay in EU
• Military application, opportunity for DoD “Deployment” sal
Sample Market Requirements for Molecular Tests
to result • Confirmatory test following a lateral flow (sensi ivity)
• Travel requirements, flight, quarantine
• Occupational Health / return to work
10
mins Market requirement for rapid results
• Urgent travel…failure of postal system and other walk-in’s
• Risk of transmission….large care homes, dentists, elite sports, cruises
• Emergency care….Healthcare workers
• Private provision - pharmacies
Route to market
• Commercial Partners focussed on service provision, rather than end users
• Expect transfer price of £20-30 per test and units around £2,000
20
mins
Post CE Marking term
• UK entrance via existing prov ders of testing solutions
GENEDRIVE® COV-19 ID KIT LAUNCH • Point of Care product with
(SARS COV-2 POC) PHASEend of performance differentiating features
cal year
BIOPLEX® US MILITARY • new US commercial partner established
GENEDRIVE® HCV-ID ON-MARKET • capitalize on drug funding available
GENEDRIVE® post-Covid
96 SARS-COV-2 • small opportunities remain, e.g. Africa
ADDITIONAL TARGETED ASSAYS • Development opportunities for
menu build on technology platform
16% up in Frankfurt?
https://finance.yahoo.com/quote/D6M.F
"One of the advantages of Lamp testing, as opposed to lateral flow, is that you can do sequencing directly from the original sample that was submitted for saliva testing and so there is no requirement to go back to people and get another sample, with all the delays. Those delays are problematic because if it’s a delay of several days and someone is infectious, they could have gone on to pass it to others.
“So, if you absolutely wanted to nail it as omicron and stop transmission, as UKHSA is trying to do at the moment, you need quick processes which are generally not achieved with lateral flow tests.”
Another testing expert echoed this, saying: “The benefits of Lamp are the quick turn-around. There are very minor prep stages and then as little as 25 minutes on the detection instrument as it does not require ‘thermocycling’ to achieve amplification like PCR does.”
They added that reagents, a substance that is added during the testing process to cause a chemical reaction for Lamp tests, can be ten times cheaper than the ones for PCR tests.
Simon Webster
Non-executive Director
Simon Linley Webster
Simon is a highly experienced software and technology entrepreneur, and most recently was Chief Executive Officer of CPA Global, a global leader in intellectual property software and tech-enabled services. Simon led CPA Global over a 20-year period, growing it from an initial £50 million business into $6.0 billion of enterprise value before its merger with NYSE listed Clarivate Plc (NYSE: CCC) in October 2020.
His early career was spent in the UK financial services sector leading business change, delivering technology transformations, and supporting M&A transactions.
Simon has been investing in and working with founders of growth businesses as Founder and CEO of SHUFL Capital since 2010. He is also a Fellow of the Chartered Institute of Management Accountants.
.
MAIN MARKET
Technology-focused shell Red Capital (REDC) raised £4m at 10p a share and after expenses it has total cash of £725,000. The shares certainly jumped when trading commenced and closed at 25.5p. This is the latest vehicle floated by Marwyn Capital founder David Williams.
https://www.branduk.net/quoted-micro-22-november-2021/
https://t.me/REDCAPITALPLC
This could b very interesting